PL4536686T3 - Kapsyd aav zmodyfikowany peptydem o zwiększonej skuteczności transdukcji mięśniowej - Google Patents

Kapsyd aav zmodyfikowany peptydem o zwiększonej skuteczności transdukcji mięśniowej

Info

Publication number
PL4536686T3
PL4536686T3 PL23728832.9T PL23728832T PL4536686T3 PL 4536686 T3 PL4536686 T3 PL 4536686T3 PL 23728832 T PL23728832 T PL 23728832T PL 4536686 T3 PL4536686 T3 PL 4536686T3
Authority
PL
Poland
Prior art keywords
peptide
aav capsid
transduction efficiency
increased muscle
muscle transduction
Prior art date
Application number
PL23728832.9T
Other languages
English (en)
Inventor
Isabelle Richard
Ai Vu HONG
Original Assignee
Genethon
Institut National de la Santé et de la Recherche Médicale
Universite D'evry Val D'essonne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genethon, Institut National de la Santé et de la Recherche Médicale, Universite D'evry Val D'essonne filed Critical Genethon
Publication of PL4536686T3 publication Critical patent/PL4536686T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14145—Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Manufacturing & Machinery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL23728832.9T 2022-06-10 2023-06-09 Kapsyd aav zmodyfikowany peptydem o zwiększonej skuteczności transdukcji mięśniowej PL4536686T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22305845 2022-06-10
PCT/EP2023/065499 WO2023237748A1 (en) 2022-06-10 2023-06-09 Peptide-modified aav capsid with enhanced muscle transduction efficiency

Publications (1)

Publication Number Publication Date
PL4536686T3 true PL4536686T3 (pl) 2026-03-23

Family

ID=82482893

Family Applications (1)

Application Number Title Priority Date Filing Date
PL23728832.9T PL4536686T3 (pl) 2022-06-10 2023-06-09 Kapsyd aav zmodyfikowany peptydem o zwiększonej skuteczności transdukcji mięśniowej

Country Status (10)

Country Link
EP (2) EP4707399A3 (pl)
JP (1) JP2025519578A (pl)
CN (1) CN119403823A (pl)
CA (1) CA3257637A1 (pl)
DK (1) DK4536686T3 (pl)
ES (1) ES3057171T3 (pl)
FI (1) FI4536686T3 (pl)
PL (1) PL4536686T3 (pl)
PT (1) PT4536686T (pl)
WO (1) WO2023237748A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025133247A1 (en) 2023-12-21 2025-06-26 Genethon Methods for aav vector re-administration
WO2026017727A1 (en) 2024-07-16 2026-01-22 Genethon Alternative barcoding method to assess transduction efficiency of aav vectors
WO2026041758A1 (en) 2024-08-22 2026-02-26 Genethon Modified aav capsid with enhanced transduction efficiency
CN121203037B (zh) * 2025-09-26 2026-05-12 北京因诺惟康医药科技有限公司 基于整合素改造的特异性靶向心脏及肌肉的aav9优势突变体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112004925B (zh) 2018-04-05 2024-09-27 吉尼松公司 具有降低的肝向性的AAV9和AAVrh74的杂合重组腺相关病毒血清型
CA3097375A1 (en) 2018-04-27 2019-10-31 Universitat Heidelberg Modified aav capsid polypeptides for treatment of muscular diseases
WO2022020616A1 (en) * 2020-07-22 2022-01-27 The Broad Institute, Inc. Engineered muscle targeting compositions
WO2022053630A1 (en) * 2020-09-10 2022-03-17 Genethon Peptide-modified aav capsid

Also Published As

Publication number Publication date
FI4536686T3 (fi) 2026-01-13
PT4536686T (pt) 2025-12-26
EP4536686B1 (en) 2025-11-19
JP2025519578A (ja) 2025-06-26
CA3257637A1 (en) 2023-12-14
EP4707399A2 (en) 2026-03-11
EP4707399A3 (en) 2026-05-06
EP4536686A1 (en) 2025-04-16
ES3057171T3 (en) 2026-02-26
WO2023237748A1 (en) 2023-12-14
CN119403823A (zh) 2025-02-07
DK4536686T3 (da) 2025-12-22

Similar Documents

Publication Publication Date Title
DK4536686T3 (da) Peptidmodificeret aav-kapsel med forbedret muskeltransduktionseffektivitet
JP1754186S (ja) ヘアブラシ
JP1752397S (ja) ヘアブラシ
EP3961047A4 (en) SILENCED BLOWER
HU5165U (hu) Javított hatékonyságú evezõlapát
TH25750Y (th) อุปกรณ์สั่นปอด
TH25750U (th) อุปกรณ์สั่นปอด
JP1759679S (ja) ステープラー
JP1776259S (ja) ヘアブラシ
JP1762838S (ja) ヘアブラシ
JP1765178S (ja) ヘアブラシ
JP1743820S (ja) ステープラー
JP1743822S (ja) ステープラー
JP1743821S (ja) ステープラー
JP1754504S (ja) ヘアブラシ
JP1753804S (ja) ヘアブラシ
JP1754500S (ja) ヘアブラシ
JP1757274S (ja) ヘアブラシ
JP1754187S (ja) ヘアブラシ
JP1754221S (ja) ヘアブラシ
JP1729599S (ja) ステープラー
JP1794891S (ja) 歯ブラシ用柄
JP1794892S (ja) 歯ブラシ用柄
JP1806010S (ja) 歯ブラシの柄
JP1806009S (ja) 歯ブラシの柄